Radio and PodcastLive Radio & Podcasts
Science & Medicine
Immune Checkpoint Inhibitors May Improve Outcomes in High-Risk Solid Tumors
Cancer immunotherapy has transformed the treatment landscape for many advanced cancers over the past decade. Drugs targeting the PD-1 and PD-L1 pathways are now widely used across several tumor types, helping the immune...
About This Episode
Immune Checkpoint Inhibitors May Improve Outcomes in High-Risk Solid Tumors is an episode from Oncotarget by Oncotarget Podcast. Cancer immunotherapy has transformed the treatment landscape for many advanced cancers over the past decade. Dr...
Podcast
This episode belongs to Oncotarget.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published May 20, 2026, 00:04:13 long, audio available.
Related Episodes
Continue listening to more episodes from Oncotarget.
Targeted Therapies Coincided With Dramatic Decline in Multiple Myeloma Mortality in the US
Jun 29, 2026 - 00:06:17
TRAIL-R2 Silencing Linked to More Aggressive Breast Cancer
Jun 24, 2026 - 00:04:28
Protein Linked to Melanoma Growth May Suppress the Body’s Natural Anti-Tumor Immune Response
Jun 17, 2026 - 00:04:33
PDX1 May Link Metabolic Dysfunction to Prostate Cancer Progression
Jun 16, 2026 - 00:08:07
HPV Vaccine Shows Safety but Uncertain Benefit in Preventing Head & Neck Cancer Recurrence
Jun 15, 2026 - 00:04:36
Experimental Compounds Trigger Cancer Cell Death in KRAS-Driven Pancreatic Cancer
Jun 8, 2026 - 00:05:14